SG Americas Securities
ABEO icon

SG Americas Securities’s Abeona Therapeutics ABEO Stock Holding History

SG Americas Securities’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,731
Closed -$57K – 3168
2025
Q4 		$57K Buy
+10,731
New +$54K ﹤0.01% 3338
2025
Q3 		– Sell
-21,765
Closed -$124K – 3350
2025
Q2 		$124K Buy
+21,765
New +$124K ﹤0.01% 2537
2021
Q1 		– Sell
-488
Closed -$19K – 3232
2020
Q4 		$19K Buy
+488
New +$16.6K ﹤0.01% 3208
2020
Q3 		– Sell
-2,588
Closed -$189K – 2638
2020
Q2 		$189K Buy
2,588
+2,108
+439% +$146K ﹤0.01% 2901
2020
Q1 		$25K Sell
480
-887
-65% -$59.2K ﹤0.01% 3276
2019
Q4 		$112K Sell
1,367
-400
-23% -$28.2K ﹤0.01% 2889
2019
Q3 		$100K Buy
1,767
+650
+58% +$48.7K ﹤0.01% 2728
2019
Q2 		$134K Sell
1,117
-133
-11% -$22.3K ﹤0.01% 2650
2019
Q1 		$230K Buy
1,250
+341
+38% +$61K ﹤0.01% 2471
2018
Q4 		$162K Buy
909
+174
+24% +$37.9K ﹤0.01% 2491
2018
Q3 		$235K Buy
+735
New +$261K ﹤0.01% 2486
2018
Q1 		– Sell
-551
Closed -$218K – 3205
2017
Q4 		$218K Buy
+551
New +$228K ﹤0.01% 2376
2016
Q2 		– Sell
-650
Closed -$42K – 2569
2016
Q1 		$42K Buy
+650
New +$43K ﹤0.01% 2779

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SG Americas Securities's ABEO Position: Q1 2026 in Review

SG Americas Securities sold out of Abeona Therapeutics (ABEO) in Q1 2026, closing a stake of 10,731 shares — an estimated $57K sold.

SG Americas Securities first reported a position in ABEO in Q1 2016 and held it in 13 quarters. The position peaked at $235K in Q3 2018. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • SG Americas Securities reported no remaining Abeona Therapeutics position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 10,731 Abeona Therapeutics shares in Q1 2026, an estimated $57K.
  • SG Americas Securities first reported a position in Abeona Therapeutics in Q1 2016 and held it in 13 quarters.
  • SG Americas Securities's Abeona Therapeutics position peaked at $235K in Q3 2018.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.